Approximately three million Americans have inflammatory bowel disease (IBD). IBD is an umbrella term for Crohn’s disease and ...

People of color with inflammatory bowel disease aren’t getting access to the same level of care as their white peers, a new ...

Patients with LVV and IBD present with distinct clinical characteristics, including earlier onset and more severe vascular involvement.

Using vedolizumab first, before tumor necrosis factor-α inhibitors, improved quality-adjusted life-years in both ulcerative ...

Morphic Therapeutic Inc. has divulged integrin α4β7 (LPAM-1) antagonists reported to be useful for the treatment of inflammatory bowel disease (IBD).

A study published today in the American Journal of Gastroenterology reveals significant disparities in healthcare utilization ...

Inflammatory bowel disease (IBD) affects around 5 million people around the world. It results in a number of gastrointestinal ...